#47 - Bill Peters, CEO at On Target Laboratories episode artwork

EPISODE · Feb 25, 2025 · 15 MIN

#47 - Bill Peters, CEO at On Target Laboratories

from BioBreakthroughs · host Slice of Healthcare LLC

Join us on the latest episode! Our Guest: Bill Peters, CEO at On Target Laboratories.What you'll get out of this episode:Innovative Imaging for Surgery – On Target Laboratories enables surgeons to see cancer at the cellular level using near-infrared imaging.Cytalux for Lung & Ovarian Cancer – Their FDA-approved drug, Cytalux, helps identify tumors in real-time, improving surgical outcomes.Surgeon-Driven Development – Continuous feedback from surgeons drives research, refining the technology for broader applications.Future of Cancer Surgery – With ongoing clinical trials, On Target Laboratories aims to expand its imaging technology to new indications.Industry Engagement – The company actively participates in key medical conferences, connecting with experts to advance cancer care.To Learn More About Our Guest And Their Company:Guest LinkedIn https://www.linkedin.com/in/bill-peters-749a332a/Company LinkedIn https://www.linkedin.com/company/on-target-laboratories-inc/ Website http://www.ontargetlabs.com Our sponsor for this episode are:Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Join us on the latest episode! Our Guest: Bill Peters, CEO at On Target Laboratories.What you'll get out of this episode:Innovative Imaging for Surgery – On Target Laboratories enables surgeons to see cancer at the cellular level using near-infrared imaging.Cytalux for Lung & Ovarian Cancer – Their FDA-approved drug, Cytalux, helps identify tumors in real-time, improving surgical outcomes.Surgeon-Driven Development – Continuous feedback from surgeons drives research, refining the technology for broader applications.Future of Cancer Surgery – With ongoing clinical trials, On Target Laboratories aims to expand its imaging technology to new indications.Industry Engagement – The company actively participates in key medical conferences, connecting with experts to advance cancer care.To Learn More About Our Guest And Their Company:Guest LinkedIn https://www.linkedin.com/in/bill-peters-749a332a/Company LinkedIn https://www.linkedin.com/company/on-target-laboratories-inc/ Website http://www.ontargetlabs.com Our sponsor for this episode are:Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

NOW PLAYING

#47 - Bill Peters, CEO at On Target Laboratories

0:00 15:11

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioBreakthroughs?

This episode is 15 minutes long.

When was this BioBreakthroughs episode published?

This episode was published on February 25, 2025.

What is this episode about?

Join us on the latest episode! Our Guest: Bill Peters, CEO at On Target Laboratories.What you'll get out of this episode:Innovative Imaging for Surgery – On Target Laboratories enables surgeons to see cancer at the cellular level using near-infrared...

Can I download this BioBreakthroughs episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!